<DOC>
	<DOCNO>NCT00000172</DOCNO>
	<brief_summary>Galantamine experimental drug evaluate United States treatment Alzheimer 's disease . Results previous clinical trial suggest galantamine may improve cognitive performance individual Alzheimer 's disease . It cure Alzheimer 's disease . Nerve cell brain responsible memory cognitive function communicate use chemical call acetylcholine . Research show deterioration cell produce acetylcholine brain affect thought process . Galantamine think work two way increase amount acetylcholine available brain . It inhibit enzyme break acetylcholine also stimulate nicotinic receptor brain release acetylcholine .</brief_summary>
	<brief_title>Evaluation Galantamine Treatment Alzheimer 's Disease</brief_title>
	<detailed_description>After 1-month single-blind run phase , 910 subject titrate , period 8 week , target dos either : 0 ( placebo ) ; 24 mg/day galantamine ; 16 mg/day galantamine ; 8 mg/day galantamine , 2:2:2:1 randomization ratio . Double-blind treatment continue total 5 month . The change baseline ADAS-cog CIVIC-plus score Month 5 primary efficacy endpoint . Tolerability evaluate base adverse event report , laboratory value , ECG , vital sign particular focus adverse event rate slower titration schedule 24 mg/day . Efficacy 24 mg/day 16 mg/day galantamine compare placebo . Information dose response relationship galantamine evaluate .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Galantamine</mesh_term>
	<criteria>Probable Alzheimer 's disease MiniMental State Examination ( MMSE ) 1022 ADAS great equal 18 Alzheimer 's Disease Assessment Scale cognitive portion ( ADAScog11 ) score least 18 Opportunity Activities Daily Living Caregiver Subjects live regular daily visit responsible caregiver ( visit frequency : preferably daily least 5 days/week ) . This include friend relative pay personnel . The caregiver capable assist subject 's medication , prepared attend subject assessment , willing provide information subject . Conditions could confound diagnosis Neurodegenerative disorder Acute cerebral trauma Psychiatric disease More one infarct CT/MRI scan History alcohol drug abuse Contradictions cholinominetic agent : seizure ; ulcer ; pulmonary condition ( include severe asthma ) ; unstable angina ; Afib ; bradycardia less 50 ; AV block .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2002</verification_date>
	<keyword>Alzheimer 's disease</keyword>
	<keyword>Cholinergic agent</keyword>
	<keyword>Cholinergic agonist</keyword>
	<keyword>Cholinesterase inhibitor</keyword>
</DOC>